Chinese expert consensus on additional surgery following endoscopic resection for early colorectal cancer (2025 edition).

IF 12.4 2区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL
Zhipeng Qi, Fuqiang Zhao, Xuhua Hu, Yunshi Zhong, Qian Liu, Zhongtao Zhang, Guiying Wang
{"title":"Chinese expert consensus on additional surgery following endoscopic resection for early colorectal cancer (2025 edition).","authors":"Zhipeng Qi, Fuqiang Zhao, Xuhua Hu, Yunshi Zhong, Qian Liu, Zhongtao Zhang, Guiying Wang","doi":"10.20892/j.issn.2095-3941.2025.0784","DOIUrl":null,"url":null,"abstract":"<p><p>Early colorectal cancer is often treated through endoscopic procedures to remove tumors. However, when initial removal is incomplete or shows high-risk features, further major surgery is required to ensure no cancer remains. This consensus provides a standard for surgeons to decide when and how to perform this additional surgery. A multidisciplinary group of Chinese medical experts reviewed global research and clinical evidence published between 2010 and 2024. The medical experts formulated key clinical recommendations, which were then discussed and finalized through expert voting to ensure high agreement. The consensus identifies specific high-risk factors necessitating additional surgery. The consensus recommends that these follow-up surgeries should ideally take place approximately 4 weeks after the first procedure. Furthermore, the consensus provides detailed protocols for marking the tumor location and selecting the best surgical approach. These consensuses offer a practical framework to improve the safety and effectiveness of treating early colorectal cancer. By standardizing surgical decisions, the consensus aims to help patients achieve better long-term recovery and quality of life.</p>","PeriodicalId":9611,"journal":{"name":"Cancer Biology & Medicine","volume":" ","pages":""},"PeriodicalIF":12.4000,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13326600/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Biology & Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20892/j.issn.2095-3941.2025.0784","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Early colorectal cancer is often treated through endoscopic procedures to remove tumors. However, when initial removal is incomplete or shows high-risk features, further major surgery is required to ensure no cancer remains. This consensus provides a standard for surgeons to decide when and how to perform this additional surgery. A multidisciplinary group of Chinese medical experts reviewed global research and clinical evidence published between 2010 and 2024. The medical experts formulated key clinical recommendations, which were then discussed and finalized through expert voting to ensure high agreement. The consensus identifies specific high-risk factors necessitating additional surgery. The consensus recommends that these follow-up surgeries should ideally take place approximately 4 weeks after the first procedure. Furthermore, the consensus provides detailed protocols for marking the tumor location and selecting the best surgical approach. These consensuses offer a practical framework to improve the safety and effectiveness of treating early colorectal cancer. By standardizing surgical decisions, the consensus aims to help patients achieve better long-term recovery and quality of life.

中国专家共识:早期结直肠癌内镜切除后附加手术(2025年版)。
早期结直肠癌通常通过内窥镜手术切除肿瘤。然而,当最初的切除不完全或显示出高风险特征时,需要进一步的大手术以确保没有癌症残留。这一共识为外科医生决定何时以及如何进行这种额外手术提供了一个标准。一个由中国医学专家组成的多学科小组审查了2010年至2024年间发表的全球研究和临床证据。医学专家制定了关键的临床建议,然后通过专家投票进行讨论和最终确定,以确保高度一致。共识确定了需要额外手术的特定高危因素。一致建议这些后续手术最好在第一次手术后约4周进行。此外,共识提供了标记肿瘤位置和选择最佳手术入路的详细协议。这些共识为提高早期结直肠癌治疗的安全性和有效性提供了一个实用的框架。通过标准化手术决策,共识旨在帮助患者实现更好的长期恢复和生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Biology & Medicine
Cancer Biology & Medicine Medicine-Oncology
CiteScore
9.80
自引率
3.60%
发文量
1143
审稿时长
12 weeks
期刊介绍: Cancer Biology & Medicine (ISSN 2095-3941) is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书